Company · CIK 1855175
Contineum Therapeutics, Inc.
| CIK | 1855175 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | CTNM (Nasdaq) |
| First annual or quarterly report | 2024-05-16 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-287275 | 2025-05-14 | 2026-03-05 | 5 | |
| 333-278003 | 2024-03-15 | 2024-04-08 | 4 |
Filings
10| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-05 | 424B5Shelf takedown | 333-287275 | 0001628280-26-015205 |
| 2025-12-12 | 424B5Shelf takedown | 333-287275 | 0001437749-25-037749 |
| 2025-12-11 | 424B5Shelf takedown | 333-287275 | 0001437749-25-037553 |
| 2025-05-23 | EFFECTDeclared effective | 333-287275 | 9999999995-25-001732 |
| 2025-05-14 | S-3Shelf registered | 333-287275 | 0001437749-25-016871 |
| 2024-04-08 | 424B4Final prospectus | 333-278003 | 0001193125-24-088740 |
| 2024-04-04 | EFFECTDeclared effective | 333-278003 | 9999999995-24-000863 |
| 2024-04-01 | S-1/AAmendment | 333-278003 | 0001193125-24-082755 |
| 2024-03-15 | S-1Registration filed | 333-278003 | 0001193125-24-069256 |
| 2023-12-13 | DRSDraft made public | 377-06994 | 0000950123-23-011163 |